Table 1: Distribution of clinicopathologic parameters according to the type of carcinoma.

ParametersGSC 
(9.2)
PGC 
(49.4)
EGJC 
(41.4)
P value

Gender <0.001
 Male44 (93.6)164 (64.8)157 (74.1)
 Female3 (6.4)89 (35.2)55 (25.9)
Resection status0.011
 R042 (89.4)152 (83.1)70 (70.7)
 R1/R25 (10.6)31 (16.9)29 (29.3)
Macroscopy 0.007
 Fungat./ulcerofungat. 24 (52.2)76 (32.2)83 (43.0)
 Ulcerating/ulceroinfilt.15 (32.6)140 (59.3)91 (47.2)
 Infiltrative7 (15.2)20 (8.5)19 (9.8)
Lauren classification 0.008
 Intestinal25 (55.6)106 (44.2)112 (58.6)
 Diffuse5 (11.1)57 (23.8)24 (12.6)
 Unclassified 15 (33.3)77 (32.1)55 (28.8)
Depth of wall penetration0.003
 pT13 (6.5)48 (19.6)16 (7.9)
 pT25 (10.9)20 (8.2)26 (12.9)
 pT322 (47.8)90 (36.7)70 (34.7)
 pT416 (34.8)87 (35.5)90 (44.6)
Nodal metastases0.49
 Absent 17 (36.2)82 (35.7)53 (30.3)
 Present 30 (63.8)148 (64.3)122 (69.7)
Nodal metastases0.013
 pN017 (36.2)82 (35.7)53 (30.3)
 pN111 (23.4)40 (17.4)31 (17.7)
 pN213 (27.7)28 (12.2)38 (27.7)
 pN36 (12.8)80 (34.8)53 (30.3)
Nodal ratio0.48
 ≤20%27 (57.4)140 (61.7)92 (55.8)
 >20%20 (42.6)87 (38.3)73 (44.2)
Lymphatic vessels invasion0.004
 Absent6 (12.8)61 (25.3)28 (13.6)
 Present41 (87.2)180 (74.7)178 (86.4)
Venous invasion0.26
 Absent19 (40.4)109 (45.0)76 (37.4)
 Present28 (59.6)133 (55.0)127 (62.6)
Distant metastasis 0.39
 Absent 45 (95.7)225 (90.0)188 (92.2)
 Present 2 (4.3)25 (10.0)16 (7.8)
AJCC stage 0.076
 I-II21 (45.7)111 (48.9)65 (37.6)
 III-IV25 (54.3)116 (51.1)108 (62.4)

Values in parentheses are percentages unless indicated otherwise.